by: Erica N. White, J.D.; Jennifer L. Piatt, J.D. The 2023-24 U.S. Supreme Court term contains multiple cases with significant nation-wide impacts on public health, including FDA powers to regulate […]

By: Max Mashal, Juris Doctor Candidate (Class of 2025), Sandra Day O’Connor College of Law at Arizona State University Introduction On September 29, 2023, the U.S. Food and Drug Administration […]

By Marki Stewart, Coppersmith Brockelman In a landmark Advisory Opinion, the U.S. Department of Health and Human Services’ Office of the Inspector General (“OIG”) confirmed its expansive view of the […]